Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Morphic Holding Inc (NQ: MORF ) 56.99 UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Morphic Holding Inc < Previous 1 2 3 4 5 Next > Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set October 09, 2023 From Morphic Therapeutic Via GlobeNewswire MORF INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into Morphic Holding, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm September 29, 2023 From Robbins Geller Rudman & Dowd LLP Via Business Wire Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review September 29, 2023 But it's not a confirmed uptrend yet. Nike, Amazon and Meta were in focus. Via Investor's Business Daily Where Morphic Holding Stands With Analysts September 28, 2023 Via Benzinga Morphic Holding Inc. (NASDAQ: MORF) is a Stock Spotlight on 7/17 July 17, 2023 Via Investor Brand Network Morphic Holding Inc. (NASDAQ: MORF) is a Stock Spotlight on 6/5 June 05, 2023 Via Investor Brand Network Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence September 26, 2023 From Morphic Therapeutic Via GlobeNewswire Gold Moves Lower; TransCode Therapeutics Shares Surge September 25, 2023 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to... Via Benzinga Topics Stocks Exposures US Equities Morphic Therapeutic's Stock Plunges On Monday - Here's Why? September 25, 2023 Since Friday, Morphic Therapeutic (NASDAQ: MORF) shares have plunged from $47.92 to $26.25 after the company announced the publication of an abstract discussing new EMERALD-1 phase 2a primary results... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session September 25, 2023 Via Benzinga Morphic Holding Inc. (NASDAQ: MORF) is a Stock Spotlight on 5/10 May 10, 2023 Via Investor Brand Network Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session September 25, 2023 Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. Via Benzinga The Surprise That Prompted Morphic Therapeutic To Dump 52% Over Two Days September 25, 2023 The company is working on a treatment for ulcerative colitis. But competitive questions linger. Via Investor's Business Daily Nasdaq Turns Higher; SCYNEXIS Shares Plunge September 25, 2023 U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded down 0.01% to 33,962.53 while the NASDAQ rose 0.26% to 13,246.15. The S&P 500... Via Benzinga Topics Stocks Exposures US Equities Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023 September 25, 2023 Via Benzinga Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023 September 22, 2023 From Morphic Therapeutic Via GlobeNewswire Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session September 22, 2023 Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 22, 2023 Via Benzinga Morphic Announces Participation in 2023 Wells Fargo Healthcare Conference August 29, 2023 From Morphic Therapeutic Via GlobeNewswire Morphic to Present at the Canaccord Genuity 43rd Annual Growth Conference August 09, 2023 From Morphic Therapeutic Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023 August 09, 2023 Via Benzinga Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023 August 03, 2023 From Morphic Therapeutic Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023 July 21, 2023 Via Benzinga 3 Stocks That Could Skyrocket by This Time Next Summer June 08, 2023 The best stocks to skyrocket in June have all done well in 2023 and over the past year. They definitely ought to be on your watchlist. Via InvestorPlace Morphic to Present at the Jefferies Global Healthcare Conference June 06, 2023 From Morphic Therapeutic Via GlobeNewswire Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference May 12, 2023 From Morphic Therapeutic Via GlobeNewswire Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative Colitis May 11, 2023 -Data demonstrate increases in circulating plasmablasts, consistent with the increased antibody activity expected with anti-inflammatory mechanism of A4B7 inhibition- From Morphic Therapeutic Via GlobeNewswire Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares May 05, 2023 From Morphic Therapeutic Via GlobeNewswire More Than $47M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying May 05, 2023 Although US stocks closed lower on Thursday, there were a few notable insider trades. Via Benzinga Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering May 03, 2023 From Morphic Therapeutic Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.